What Fueled The Previous Growth In The Bioprocess Analyzers Market?
The bioprocess analyzers market has seen considerable growth due to a variety of factors.
• Over the past few years, there has been a swift expansion in the bioprocess analyzers market size. The market that was worth $1.99 billion in 2024 is predicted to reach $2.2 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.8%.
Factors contributing to this growth during the historical period include the rising demand for personalized medicine and the escalating intricacy of bioprocesses.
How Does the Forecast Look for the Bioprocess Analyzers Market?
The bioprocess analyzers market is expected to maintain its strong growth trajectory in upcoming years.
• The market for bioprocess analyzers is anticipated to experience swift expansion in the coming years, growing to a worth of $3.27 billion by 2029, with a compound annual growth rate (CAGR) of 10.4%.
The expected growth during this forecast period is linked to the rise in biosimilar and biobetter products, the growth of bioprocessing sectors, and the increase in R&D investment. The projected trends within this period encompass the broadening of real-time monitoring, the introduction of advanced sensors, and an emphasis on automation and connectivity.
What Are The Leading Drivers Of Growth In The Bioprocess Analyzers Market?
The bioprocess analyzer market is predicted to be driven by an increase in the demand for biopharmaceuticals. Biopharmaceuticals, pharmaceuticals derived from biological sources or components of living organisms, is a burgeoning industry due to innovative research and development activities that lead to the production of new biologics and biosimilars. Bioprocess analyzers play a crucial role in overseeing various facets of biopharmaceutical production including monitoring cell growth, protein expression, and product purity. As per IQVIA, a firm based in the US that provides services for biopharmaceutical development, by 2028, the global biotech expenditure is projected to surpass $892 billion as of January 2024. Hence, the burgeoning demand for biopharmaceuticals is set to fuel the expansion of the bioprocess analyzer market.
How Are The Segments Defined Within The Global Bioprocess Analyzers Market?
The bioprocess analyzers market covered in this report is segmented –
1) By Product: Instruments, Consumables
2) By Application: Antibiotics, Recombinant Proteins, Biosimilars, Other Applications
3) By End-User: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Other End Users
Subsegments:
1) By Instruments: Spectrometers, Chromatographs, pH Or DO Analyzers, Gas Analyzers, Flow Cytometers, Offline Analyzers
2) By Consumables: Reagents, Sensors, Calibration Kits, Culture Media, Filters
Pre-Book The Bioprocess Analyzers Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Shaping The Bioprocess Analyzers Market?
Leading firms in the bioprocess analyzer sector are prioritizing the creation of innovative solutions, like optical in-line analyzers, to establish a robust market presence. These analyzers employ the use of optical technology to offer instantaneous monitoring and assessment of crucial elements in bioprocessing tasks. As an example, 908 Devices Inc., a US firm specializing in chemical and biochemical assessments, introduced MAVERICK in September 2023. This state-of-the-art optical in-line analyzer offers real-time observation and regulation of essential variables such as glucose, lactate, and the overall biomass in mammalian cell cultures. Biopharmaceutical specialists can use the device's comprehensive process fingerprint data to optimize large-scale bioprocesses. Its user-friendly interface eases the workload of scientists and engineers, expediting the development of cell culture mediums and effective feeding and control plans. It employs Raman spectroscopy to measure various crucial process parameters, such as glucose, lactate, and biomass, in bioreactors in real time. Maverick is designed to enhance process understanding, boost performance, and guarantee consistent batch reproduction in cell culture automation for biological production using CHO (Chinese hamster ovary) or HEK293 (human embryonic kidney 293) mammalian cell lines and several medium types.
Who Are the Key Players In The Bioprocess Analyzers Market?
Major companies operating in the bioprocess analyzers market are:
• Danaher Corporation
• Merck KGaA
• Becton Dickinson and Company
• Thermo Fisher Scientific
• MilliporeSigma
• Sartorius AG
• Beckman Coulter Inc.
• Waters Corporation
• Bio-Rad Laboratories
• Bruker Corporation
• Agilent Technologies
• GE Healthcare
• Pall Corporation
• Eppendorf AG
• HORIBA Ltd.
• Promega Corporation
• Nova Biomedical
• Hamilton Company
• Macherey-Nagel GmbH & Co. KG
• BioTek Instruments
• Zymo Research Corporation
• Gilson Inc.
• Metrohm AG
• Biochrom Ltd.
• PerkinElmer Inc.
What Is The Most Dominant Region In The Bioprocess Analyzers Market?
North America was the largest region in the bioprocess analyzers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioprocess analyzers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
